Natus Medical Incorporated (NASDAQ:BABY) Files An 8-K Submission of Matters to a Vote of Security Holders
ITEM 5.07.
|
Submission of Matters to a Vote of Security Holders
|
its annual meeting of stockholders. At this meeting, Kenneth E.
Ludlum and Barbara R. Paul were re-elected to serve on the Board
of Directors for a three-year term until 2020. Additionally,
shareholders ratified the appointment of KPMG as the Companys
independent registered public accounting firm for the fiscal year
ending December 31, 2017 and provided advisory approval of the
Companys named executive officer compensation and recommendation
of the frequency of voting.
|
Nominee
|
|||||||
|
For
|
Against
|
Abstain
|
Broker
Non-Votes
|
||||
|
Kenneth E. Ludlum
|
25,284,630
|
1,261,855
|
9,350
|
4,356,069
|
|||
|
Barbara R. Paul
|
25,672,816
|
874,412
|
8,607
|
4,356,069
|
|||
|
Proposal 2: Ratification of KPMG as Auditors
|
|||||||
|
For
|
Against
|
Abstain
|
|||||
|
30,445,887
|
15,257
|
450,760
|
|||||
|
Proposal 3: Recommend Frequency of Advisory Vote on
Executive Compensation |
|||||||
|
1 Year
|
2 Years
|
3 Years
|
Abstain
|
||||
|
21,872,989
|
28,394
|
4,634,548
|
19,904
|
||||
|
Proposal 4: Advisory Approval of the Companys Executive
Compensation |
|||||||
|
For
|
Against
|
Abstain
|
Broker
Non-Votes
|
||||
|
23,985,666
|
2,447,485
|
122,684
|
4,356,069
|
||||
About Natus Medical Incorporated (NASDAQ:BABY)
Natus Medical Incorporated is a provider of newborn care and neurology healthcare products and services used for the screening, diagnosis, detection, treatment, monitoring and tracking of common medical ailments in newborn care, hearing impairment, neurological dysfunction, epilepsy, sleep disorders, neuromuscular diseases and balance and mobility disorders. The Company’s segment is neurology and newborn care product families. Its product offerings include computerized neurodiagnostic systems for audiology, neurology, polysomnography, and neonatology, as well as newborn care products, such as hearing screening systems, phototherapy devices for the treatment of newborn jaundice, head-cooling products for the treatment of brain injury in newborns, incubators to control the newborn’s environment, and software systems for managing and tracking disorders and diseases for public health laboratories. It is organized into two strategic business units: Neurology and Newborn Care.